归脾丸改善血液透析患者贫血及对炎症因子的影响

孙杰; 马俊杰; 张以来; 魏善斋

归脾丸改善血液透析患者贫血及对炎症因子的影响

1.
沭阳县中医院肾病科，江苏宿迁 223600
2.
南京中医药大学基础医学院，江苏南京 210023

计量
- 文章访问数: 733
- HTML全文浏览量: 19
- PDF下载量: 624
- 被引次数: 0
出版历程
- 刊出日期: 2016-01-10

Guipi Pills in Treating Anemia of Patients Receiving Hemodialysis and the Influence on the Inflammatory Factors

1.
Nephrology Department of Shuyang TCM Hospital, Suqian, 223600, China
2.
The Basic Medical School of Nanjing University of Chinese Medicine, Nanjing, 210023, China

摘要

摘要: 目的探讨归脾丸对血液透析患者贫血及炎症因子的影响。方法 60例西医诊断为慢性肾脏病（CKD）5期、CKD贫血，中医诊断为脾虚、血虚证等维持性血液透析（MHD）患者随机分成2组，每组30例。对照组采用促红细胞生成素（EPO）干预治疗，治疗组在对照组基础上加用归脾丸，共治疗60 d，2组治疗前后分别检测血红蛋白（Hb）、血清超敏C-反应蛋白（hs-CRP）、白细胞介素6（IL-6）的变化。结果与治疗前比较，2组治疗后Hb明显升高（P<0.05~0.01），治疗组优于对照组（P<0.05）；与治疗前相比，2组患者hs-CRP、IL-6皆有明显下降（P<0.05~0.01），治疗组低于对照组（P<0.05~0.01）。结论归脾丸具有改善血液透析患者贫血及抗炎作用。
- 归脾丸 /
- MHD /
- 慢性肾脏病贫血 /
- 炎症因子
Abstract: OBJECTIVE To study on the influence of Guipi pills on anemia and the inflammatory factors of patients receiving hemodialysis. METHODS 60 patients diagnosed with CKD(stage 5)， CKD anemia and spleen deficiency and blood deficiency and have maintenance hemodialysis(MHD) were randomly divided into two groups with 30 cases in each group. The control group was treated with erythropoietin(EPO) and the treatment group， besides receiving EPO， took Guipi pills as well. The treatment lasted for 60 days. The hs-CRP， IL-6 and Hb were recorded before and after the treatment. RESULTS After the treatment， hs-CRP， IL-6 and Hb of both groups had significant decrease(P<0.05~0.01) and the treatment group was better than the control group(P<0.05~0.01). After the treatment， Hb of both groups increased(P<0.05~0.01) and still the treatment group was better than the control group(P<0.05). CONCLUSION Guipi pills are effective in treating anemia and inflammation of patients receiving hemodialysis.
- Guipi pills /
- MHD /
- chronic kidney disease (CKD) anemia /
- inflammatory factors

HTML全文

参考文献(24)

[1]	张政，徐琴君，谢桐，等.维持性血透患者肾性贫血发病机理的研究[J].临床泌尿外科杂志，1995，10（3）：141-144.
[2]	Zhang Z， Xu QJ， Xie T， et al. Pathogenesis of renal anemia of patients receiving maintenance hemodialysis[J]. J Clin Urol， 1995， 10(3):141-144.
[3]	刘光伟，杨惠标，嬴书宝.维持性血透患者贫血纠正后不同透析膜对肿瘤坏死因子α的影响[J].包头医学院学报，2013，17（1）：16-18.
[4]	Liu GW， Yang HB， Ying SB. Influence of different membranes on TNF-α after maintained hemodialysis patients' anemia is improved[J]. Baotou Med J， 2013， 17(1): 16-18.
[5]	于晓君.肾性贫血的发生机制及治疗体会[J].中国医药指南，2012，10（31）：666-667.
[6]	Yu XJ. Experience of treating renal anemia and its pathogenesis[J]. Guide Chin Pharm， 2012， 10(31):666-667.
[7]	朱世瑶，赵江，吴萍，等.促红素治疗血透患者肾性贫血的疗效与安全性观察[J].四川医学，2011，32（8）：1257-1258.
[8]	〖JP2〗Zhu SY， Zhao J， Wu P， et al. Clinical observation on the efficacy and safety of EPO in treating renal anemia in patients on maintenance hemodialysis[J]. Sichuan Med， 2011， 32(8):1257-1258.〖JP〗
[9]	查芳芳.C-反应蛋白在尿毒症维持性血液透析患者中的临床意义[J].中国临床医学，2007，14(2):213-215.
[10]	Zha FF. Clinical significance of C-reactive protein in patients undergoing maintenance hemodialysis due to uremia[J]. Clin Med J China， 2007， 14(2):213-215.
[11]	王海燕.肾脏病学[M].第3版.北京：人民卫生出版社，2008:1815-1816.
[12]	Wang HY. Nephrology[M]. 3rd edition. Beijing: People's medical publishing house， 2008: 1815-1816.
[13]	美国肾脏基金会.慢性肾脏病及透析的临床实践指南Ⅱ[S].王海燕，王梅，译.北京：人民卫生出版社，2005:4-6.
[14]	National Kidney Foundation. The national kidney foundation disease outcomes quality initiative Ⅱ[S]. Translated by Wang HY， Wang M. Beijing: People's medical publishing house， 2005: 4-6.
[15]	邓铁涛.中医诊断学[M].上海:上海科技出版社，1984:85-86.
[16]	Deng TT. Diagnostics of TCM[M]. Shanghai: Shanghai scientific and technical publishers， 1984:85-86.
[17]	葛均波，徐永健.内科学[M].北京:人民卫生出版社，2013:529-532.
[18]	Ge JB， Xu YJ. Internal Medicine[M]. Beijing: People's medical publishing house， 2013:529-532.
[19]	程静刁，易无庸，潘晓东.归脾丸治疗血透贫血患者的效果观察[J].护理学杂志，2005，20（1）：41-42.
[20]	Chen JD， Yi WY， Pan XD. Efficacy of GuiPiWan treating anemia patients during hemodialysis[J]. J Nurs Sci， 2005， 20(1):41-42.
[21]	黄霞，王树辉，刘加林.中西医结合治疗维持性血透患者贫血和微炎症状态的临床研究[J].中国中西医结合肾病杂志，2011，12（12）：1085-1087.
[22]	Huang X， Wang SH， Liu JL. Observation on curative effects in treatment for micro-inflammatory state and anemia by maintenance hemodialysis with integrated traditional Chinese and western medicine[J].Chin J Integr Tradit Chin West Med Intensive Nephrol， 2011， 12(12):1085-1087.
[23]	刘春梅，马锐，姚新生，等.维持性血液透析患者IL-17水平及与CRP关系的探讨[J].中国免疫学杂志，2009，25(5):454-458.
[24]	Liu CM， Ma R， Yao XS， et al. Exploration of IL-17 amount and its correlation to CRP in the patients with MHD[J]. Chin J Immunol， 2009， 25(5):454-458.